Spero therapeutics announces $40 million equity investment from pfizer inc. and licensing agreement for spr206

Spero grants pfizer rights to develop, manufacture, and commercialize spr206 in ex-u.s. and ex-asia territories in exchange for potential development and commercial milestone payments and royalties. spero grants pfizer rights to develop, manufacture, and commercialize spr206 in ex-u.s. and ex-asia territories in exchange for potential development and commercial milestone payments and royalties.
SPRO Ratings Summary
SPRO Quant Ranking